Application Notes & Case Studies

1. Building Confidence In Combination Product Development 11/12/2026

   Early compatibility testing with realistic placebo models helps mitigate formulation risks, ensuring accurate dosing, predictable injection times, and long-term stability.

2. Where Does Container Closure Integrity Break Down In Cold Storage? 11/9/2026

   Closure integrity qualified at ambient conditions can hide failures that appear only in deep freeze. Testing capped 2R vials across a descending temperature range pinpoints where the seal gives way.

3. From Early Development To Commercial Launch: An End-To-End Partnership 11/5/2026

   Bringing a critical therapy to market takes early coordination. See how strategic planning helped accelerate an oncology therapy from clinical development to patients.

4. Unlocking Higher Complex Capsule Yields Through More Efficient Manufacturing 11/5/2026

   Boost complex capsule output by 3–7% per batch with targeted process optimization, without formulation changes, extra batches, new equipment, or regulatory submissions.

5. Selecting The Right Chromatography Strategy 11/3/2026

   Difficult small molecule purifications rarely yield to one technique. Modeling, fraction mapping, and preparative HPLC each solve a different problem, and the right choice depends on the molecule.

6. Optimizing Particle Properties For Difficult Small Molecules 11/3/2026

   Crystal morphology and unexpected solid-state intermediates often decide whether a difficult small molecule filters, dries, and scales. Thermodynamic stability may not be the right target.

7. Turning A "Brick Dust" Compound Into A Clinically Viable Oral Formulation 11/2/2026

   Advanced wet milling and particle stabilization improve solubility, enhance bioavailability, and support scalable manufacturing for complex oral drug development programs.

8. Successful Tech Transfer Plans Ensured On-Time Launches 11/2/2026

   Successful technology transfers require proactive engineering and rigorous assessments to address equipment challenges, protect product integrity, and keep launches on schedule.

9. Creating A New Dosage Form From An Approved Drug For A New Rare Disease 11/2/2026

   Advancing approved drugs into new indications requires smart formulation, strong quality controls, and regulatory expertise to overcome challenges and accelerate patient access.

10. Why Early Device Decisions Matter: How Immunovant Accelerated Its Program 10/15/2026

    Deferring autoinjector selection can seem to preserve flexibility, yet it often moves constraints downstream. Integrating the device during Phase IIb changed one program's timeline and removed bridging work.